Re: 8 weeks into ZEN-3694 trial today

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

fouremm

Rank: President [?]

Points: 3330 [?]

Votes: 34 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: 8 weeks into ZEN-3694 trial today

in response to

8 weeks into ZEN-3694 trial today

BearDownAZ

posted on Aug 10, 2016 10:44PM

Bear, By this design and if the drug is tolerated, do you have any idea as to when we might expect to reach a dose level that would be predicted to be effacious?